Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3922 (MIR3922) is an RNA gene encoding a short (20–24 nucleotide), non-coding RNA belonging to the microRNA family. Like other microRNAs, it regulates post-transcriptional gene expression by binding to target messenger RNAs resulting in either translational inhibition or destabilization of the mRNA. MIR3922 is cataloged in gene databases (HGNC: 38895, NCBI Gene: 100500843, Ensembl: ENSG00000264295, miRBase: hsa-mir-3922) but has no reported functional roles, validated disease associations, or drug interactions in published literature or curated databases as of September 2025[3]. MicroRNAs in general play important roles in development, cell differentiation, cell cycle regulation, apoptosis, and in various human diseases such as cancer and neurodegenerative disorders[1][4][7]. However, for MIR3922, there is only theoretical and predicted annotation, and its biological functions, disease roles, and relevance as a therapeutic target remain uncharacterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3922 (MIR3922).